These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 24698140
1. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Aguiar SI, Brito MJ, Horacio AN, Lopes JP, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Paediatric Infectious Disease Society. Euro Surveill; 2014 Mar 27; 19(12):20750. PubMed ID: 24698140 [Abstract] [Full Text] [Related]
4. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Pediatr Infect Dis J; 2009 Apr 27; 28(4):277-82. PubMed ID: 19258924 [Abstract] [Full Text] [Related]
5. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013. Cho EY, Choi EH, Kang JH, Kim KH, Kim DS, Kim YJ, Ahn YM, Eun BW, Oh SH, Cha SH, Cho HK, Hong YJ, Kim KN, Kim NH, Kim YK, Kim JH, Lee H, Lee T, Kim HM, Lee KS, Kim CS, Park SE, Kim YM, Oh CE, Ma SH, Jo DS, Choi YY, Lee J, Bae GR, Park O, Park YJ, Kim ES, Lee HJ. J Korean Med Sci; 2016 Jul 27; 31(7):1082-8. PubMed ID: 27366006 [Abstract] [Full Text] [Related]
7. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ, McIntosh ED, Reinert RR. Int J Infect Dis; 2010 Mar 27; 14(3):e197-209. PubMed ID: 19700359 [Abstract] [Full Text] [Related]
8. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. De Wals P, Lefebvre B, Deceuninck G, Longtin J. Vaccine; 2018 Jan 08; 36(3):421-426. PubMed ID: 29224962 [Abstract] [Full Text] [Related]
15. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E, Albert MJ. Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356 [Abstract] [Full Text] [Related]
18. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP. Pediatr Infect Dis J; 2013 Feb 31; 32(2):e45-53. PubMed ID: 23080290 [Abstract] [Full Text] [Related]
20. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B. Eur Respir J; 2016 Apr 31; 47(4):1208-18. PubMed ID: 26797033 [Abstract] [Full Text] [Related] Page: [Next] [New Search]